|
|
Volumn 293, Issue 9, 2005, Pages 1048-1049
|
|
Experimental therapies hold promise for treating amyotrophic lateral sclerosis
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTISENSE OLIGONUCLEOTIDE;
COPPER ZINC SUPEROXIDE DISMUTASE;
DNA FRAGMENT;
LENTIVIRUS VECTOR;
RILUZOLE;
VASCULOTROPIN;
SUPEROXIDE DISMUTASE;
VASCULOTROPIN A;
AMYOTROPHIC LATERAL SCLEROSIS;
GENE MUTATION;
GENE SILENCING;
GENE THERAPY;
HUMAN;
MOTONEURON;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
RNA INTERFERENCE;
SHORT SURVEY;
STEM CELL TRANSPLANTATION;
ANIMAL;
ARTICLE;
GENETICS;
MEDICAL RESEARCH;
AMYOTROPHIC LATERAL SCLEROSIS;
ANIMALS;
BIOMEDICAL RESEARCH;
GENE THERAPY;
HUMANS;
RNA INTERFERENCE;
SUPEROXIDE DISMUTASE;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
|
EID: 14144255665
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.293.9.1048 Document Type: Short Survey |
|
Times cited : (1)
|
|
References (0)
|